Layer 1
Gastrointestinal

Refine

E.g., 25/09/2020
E.g., 25/09/2020

Refine

Refine

E.g., 25/09/2020
E.g., 25/09/2020

gastrointestinal

Disclaimer This information was written for C+D in 2011, and has not been updated to reflect any changes in clinical guidance since its publication...
12/09/2011 1
Market insight | Market changes | Best-sellers | Boost your digestive health service | Case study | Product watch | Tips for CPD entry Kathy...
26/07/2011 0
Eisai has applied for a P licence for its proton pump inhibitor rabeprazole. The company is seeking to make the prescription-only drug available...
26/07/2011 0
Prime minister David Cameron will warn today that the NHS must change to preserve free healthcare for all, the Telegraph reports. The Guardian...
07/06/2011 0
60-second summary Why read this article? Patients with ulcerative colitis and Crohn's disease require...
08/04/2011 0
Some GPs have warned about "missed opportunities" to educate young women about STDs, the BBC reports in response to the launch of a free pharmacy...
06/04/2011 0
Drugs in this class are used for: Irritable bowel syndrome Drugs in this class include alverine, mebeverine,...
01/04/2011 0
Antacids and alginates should be taken after eating. However, they should not be taken immediately prior to lying down because there is a risk of...
01/04/2011 0
Almost one in three people in the UK have experienced lower stomach cramps and pain as a result of feeling stressed or overwhelmed, according to a...
31/03/2011 0
Primary care professionals can play a key role in the treatment of gastro-oesophageal reflux disease (GORD) by carrying out patient lifestyle...
30/11/2010 0

Pages